Vir Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEOMarianne de Backer
CEOMarianne de Backer
Employees408
Employees408
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2016
Founded2016
Employees408
Employees408
VIR Key Statistics
Market cap825.71M
Market cap825.71M
Price-Earnings ratio-1.64
Price-Earnings ratio-1.64
Dividend yield—
Dividend yield—
Average volume1.76M
Average volume1.76M
High today$6.33
High today$6.33
Low today$5.92
Low today$5.92
Open price$6.20
Open price$6.20
Volume2.05M
Volume2.05M
52 Week high$14.45
52 Week high$14.45
52 Week low$4.16
52 Week low$4.16
Stock Snapshot
As of today, Vir Biotechnology(VIR) shares are valued at $6.09. The company's market cap stands at 825.71M, with a P/E ratio of -1.64.
During the trading session on 2025-12-19, Vir Biotechnology(VIR) shares reached a daily high of $6.33 and a low of $5.92. At a current price of $6.09, the stock is +3.0% higher than the low and still -3.8% under the high.
Trading activity shows a volume of 2.05M, compared to an average daily volume of 1.76M.
The stock's 52-week range extends from a low of $4.16 to a high of $14.45.
The stock's 52-week range extends from a low of $4.16 to a high of $14.45.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VIR. This list is generated using Robinhood data, and it’s not a recommendation.